News|Articles|December 12, 2025
Lipid-Based Formulation in Customized Enteric Capsule for Oral GLP-1 Receptor Agonist Peptide Delivery
Author(s)Lonza Capsugel
Multiple factors affect oral delivery of therapeutic peptides such as acidic and enzymatic degradation in the upper gastrointestinal tract and poor intestinal Permeability.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use
2
PharmTech Weekly News Roundup – Week of January 19, 2026
3
Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production
4
West Launches New Prefillable Syringe System that Streamlines Biologic Delivery
5